Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) (“Kaival
Brands,” the “Company,” or “we”), the exclusive U.S. distributor of
all products manufactured by Bidi Vapor, LLC (“Bidi Vapor”), which
are intended for adults 21 and over, today announced that it has
shipped a bulk order of BIDI® Sticks to H.T. Hackney Co.
(“Hackney”), one of the largest wholesale distributors in the
United States.
The order is valued at more than $750,000 and
was shipped in the fourth quarter of fiscal year 2023. H.T. Hackney
had not ordered more than $100,000 of BIDI® Stick product in a
single order since March 2023.
Eric Mosser, Chief Executive Officer &
President of Kaival Brands, said, “This bulk order represents the
resumption of activity with one of our key distribution partners
and is an important step towards accelerating our product sales.
Hackney is a long-term, dedicated distributor that recognizes the
important business value of only distributing compliant and
legitimate, non-illicit ENDS products and shares our commitment to
championing youth-access prevention. Given recent enforcement
efforts by the FDA to address the problem of illicit and illegal
vaping products, we are optimistic that this bulk order is an
indication of a positive trajectory in revenue growth.”
ABOUT H.T. HACKNEY
As one of the largest wholesale distributors in
the United States, Hackney services over 20,000 retail customers
and stocks over 25,000 products. With strategically located
distribution centers, Hackney provides a distribution network
easily covering 22 states.
Since 1891, Hackney has achieved its premier
market position as a result of providing superior customer service
and competitively priced merchandise. Its programs are created
around the concept of offering customers the ability to obtain
their entire store needs from one reliable source.
ABOUT KAIVAL BRANDS
Based in Grant-Valkaria, Florida, Kaival Brands
is a company focused on incubating innovative and profitable
adult-focused products into mature and dominant brands, with a
current focus on the distribution of electronic nicotine delivery
systems (ENDS) also known as “e-cigarettes”. Our business plan is
to seek to diversify into distributing other nicotine and
non-nicotine delivery system products (including those related to
hemp-derived cannabidiol (known as CBD) products). Kaival Brands
and Philip Morris Products S.A. (via sublicense from Kaival Brands)
are the exclusive global distributors of all products manufactured
by Bidi Vapor.
Learn more about Kaival Brands at
https://ir.kaivalbrands.com/overview/default.aspx.
ABOUT KAIVAL LABS
Based in Grant-Valkaria, Florida, Kaival Labs is
a 100% wholly-owned subsidiary of Kaival Brands focused on
developing new branded and white-label products and services in the
vaporizer and inhalation technology sectors. Kaival Labs’ current
patent portfolio consists of 12 existing and 46 pending with novel
technologies across extrusion dose control, product preservation,
tracking and tracing usage, multiple modalities and child safety.
The patents and patent applications cover territories including the
United States, Australia, Canada, China, the European Patent
Organisation, Israel, Japan, Mexico, New Zealand and South Korea.
The portfolio also includes a fully-functional proprietary mobile
device software application that is used in conjunction with
certain patents in the portfolio.
Learn more about Kaival Labs at
https://kaivallabs.com.
ABOUT BIDI VAPOR
Based in Melbourne, Florida, Bidi Vapor
maintains a commitment to responsible, adult-focused marketing,
supporting age-verification standards and sustainability through
its BIDI ® Cares recycling program. Bidi Vapor’s premier device,
the BIDI ® Stick, is a premium product made with high-quality
components, a UL-certified battery and technology designed to
deliver a consistent vaping experience for adult smokers 21 and
over. Bidi Vapor is also adamant about strict compliance with all
federal, state and local guidelines and regulations. At Bidi Vapor,
innovation is key to its mission, with the BIDI ® Stick promoting
environmental sustainability, while providing a unique vaping
experience to adult smokers.
Nirajkumar Patel, the Company’s Chief Science
and Regulatory Officer and director, owns and controls Bidi Vapor.
As a result, Bidi Vapor is considered a related party of the
Company.
For more information, visit
www.bidivapor.com.
Cautionary Note Regarding
Forward-Looking Statements
This press release and the statements of the
Company’s management and partners included herein and related to
the subject matter herein includes statements that constitute
“forward-looking statements” (as defined in Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended), which are statements
other than historical facts. You can identify forward-looking
statements by words such as “anticipate,” “believe,” “continue,”
“could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,”
“position,” “should,” “strategy,” “target,” “will,” and similar
words. All forward-looking statements speak only as of the date of
this press release. Although we believe that the plans, intentions,
and expectations reflected in or suggested by the forward-looking
statements are reasonable, there is no assurance that these plans,
intentions, or expectations will be achieved. Therefore, actual
outcomes and results (including, without limitation, the results of
the Company’s sales and marketing efforts with H.T. Hackney as
described herein and the impact of such efforts on the Company’s
future results of operations) could materially and adversely differ
from what is expressed, implied, or forecasted in such statements.
Our business may be influenced by many factors that are difficult
to predict, involve uncertainties that may materially affect
results, and are often beyond our control. Factors that could cause
or contribute to such differences include, but are not limited to:
(i) future actions by the FDA in response to the 11th Circuit
Court’s decision that could impact our business and prospects, (ii)
the outcome of FDA’s scientific review of Bidi Vapor’s pending FDA
Premarket Tobacco Product Applications, (iii) the results of
international marketing and sales efforts by Philip Morris
International, the Company’s international distribution partner,
(iv) how quickly domestic and international markets adopt our
products, (v) the scope of future FDA enforcement of regulations in
the ENDS industry, (vi) the FDA’s approach to the regulation of
synthetic nicotine and its impact on our business, (vii) potential
federal and state flavor bans and other restrictions on ENDS
products, (viii) the duration and scope of the COVID-19 pandemic
and impact on the demand for the products we distribute, (ix)
general economic uncertainty in key global markets and a worsening
of global economic conditions or low levels of economic growth, (x)
the effects of steps that we could take to reduce operating costs,
(xi) our inability to generate and sustain profitable sales growth,
including sales growth in U.S. and international markets, (xii)
circumstances or developments that may make us unable to implement
or realize anticipated benefits, or that may increase the costs, of
our current and planned business initiatives (including, without
limitation, the development of vaporization intellectual property
we acquired in late April 2023), (xiii) significant changes in our
relationships with our distributors or sub-distributors such as
H.T. Hackney and (xiv) other factors detailed by us in our public
filings with the Securities and Exchange Commission, including the
disclosures under the heading “Risk Factors” in our Annual Report
on Form 10-K for the fiscal year ended October 31, 2022, filed with
the Securities and Exchange Commission on January 27, 2023 as well
as all of our subsequent SEC filings, all of which are accessible
at www.sec.gov. All forward-looking statements included in
this press release are expressly qualified in their entirety by
such cautionary statements. Except as required under the federal
securities laws and the Securities and Exchange Commission’s rules
and regulations, we do not have any intention or obligation to
update any forward-looking statements publicly, whether as a result
of new information, future events, or otherwise.
Kaival Brands Investor Relations:Brett Maas,
Managing PartnerHayden IR(646) 536-7331brett@haydenir.com
Kaival Brands Media & Press
Relations:Stephen Sheriff, COO and Investor Relations
OfficerKaival Brands (646)
572-7086investors@kaivalbrands.com
Kaival Brands Innovations (NASDAQ:KAVL)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Kaival Brands Innovations (NASDAQ:KAVL)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025